Free Trial

Amplifon (OTCMKTS:AMFPF) Posts Earnings Results, Misses Expectations By $0.09 EPS

Amplifon logo with Medical background

Key Points

  • Amplifon reported a quarterly earnings per share of $0.25, with a net margin of 5.90% and a return on equity of 13.77%.
  • The stock increased by 1.2% following the earnings release, opening at $17.46 with a market capitalization of $3.94 billion.
  • Morgan Stanley has restated an "overweight" rating on Amplifon, indicating strong confidence in the company's future performance.
  • MarketBeat previews the top five stocks to own by October 1st.

Amplifon (OTCMKTS:AMFPF - Get Free Report) posted its earnings results on Thursday. The company reported $0.25 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.34 by ($0.09), Zacks reports. The company had revenue of $698.20 million during the quarter, compared to the consensus estimate of $625.73 million. Amplifon had a net margin of 5.20% and a return on equity of 13.49%.

Amplifon Price Performance

Shares of AMFPF remained flat at $17.46 on Tuesday. The company's 50-day moving average is $22.61 and its 200-day moving average is $22.81. Amplifon has a 52 week low of $16.97 and a 52 week high of $29.33. The stock has a market cap of $3.94 billion, a P/E ratio of 28.62 and a beta of 0.53. The company has a debt-to-equity ratio of 0.85, a quick ratio of 0.54 and a current ratio of 0.62.

Analyst Upgrades and Downgrades

Separately, Morgan Stanley reiterated an "overweight" rating on shares of Amplifon in a report on Wednesday, June 25th.

Read Our Latest Report on AMFPF

Amplifon Company Profile

(Get Free Report)

Amplifon S.p.A. engages in the distribution of hearing solutions and the fitting of customized products that help people rediscover various emotions of sound in Europe, the Middle East, Africa, the Americas, and the Asia Pacific. The company offers Ampli-easy, Ampli-connect, Ampli-energy, and Ampli-mini hearing devices.

Further Reading

Earnings History for Amplifon (OTCMKTS:AMFPF)

Should You Invest $1,000 in Amplifon Right Now?

Before you consider Amplifon, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Amplifon wasn't on the list.

While Amplifon currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Stocks to Buy And Hold Forever Cover

Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Markets Are Sliding: Where to Find Opportunity
5 Hot Stocks to Buy Now: September’s Top Picks With Major Momentum
$15 Billion for Cybersecurity: The Government’s Next Big Push

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines